2

Application of Circulating cell-free tumor DNA profiles for therapeutic monitoring and outcome prediction in genetically heterogeneous metastatic melanoma

*Journal of Clinical Oncology* 2019; 3:1-10

Familywise error control in multi-armed response-adaptive trials

*Biometrics* 2019; 75(3):885-894

Re-formulating Gehan's design as a flexible two-stage single-arm trial

*BMC Medical Research Methodology* 2019; 19:22

Shared heritability and functional enrichment across six solid cancers

*Nature Communications* 2019; 10:431

Adjuvant rituximab, a potential treatment for the young patient with Graves' hyperthyroidism (RiGD): Study protocol for a single-arm, single-stage, phase II trial

*BMJ Open* 2019; 9(1):e024705

A robust Bayesian meta-analytic approach to incorporate animal data into phase I oncology trials

*Statistical Methods in Medical Research* 2019; 29(1):94-110

Persistence and effectiveness of nonbiologic systemic therapies for moderate-to-severe psoriasis in adults: A systematic review

*British Journal of Dermatology* 2019; 181(2):256-264

Biomarker-guided trials: Challenges in practice

*Contemporary Clinical Trials Communications* 2019; 16:100493

Defining the therapeutic range for adalimumab and predicting response in psoriasis: A multicenter prospective observational cohort study

*Journal of Investigative Dermatology* 2019; 139(1):115-123

When to keep it simple - Adaptive designs are not always useful

*BMC Medicine* 2019; 17:152